What is brincidofovir?
Brincidofovir is anprescription medicine approved by the U.S. (FDA) for the treatment of smallpox in adults and children, including newborn infants. (Smallpox is a disease caused by the variola virus, a member of the orthopoxvirus group of viruses. Since 1980, smallpox has been considered eradicated worldwide.)
Although brincidofovir is FDA-approved only for smallpox treatment, it may also be used to treat another type of orthopoxvirus infection called. Brincidofovir may be obtained for mpox treatment through a request by a physician to FDA. (This type of request is known as an emergency request or emergency IND request.)
Mpox can be an What is an Opportunistic Infection? fact sheet.(OI) of HIV. An OI is an infection that occurs more frequently or is more severe in people with weakened —such as people with HIV—than in people with healthy immune systems. To learn more about OIs, read the HIVinfo
How is brincidofovir used in people with HIV?
The Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV include recommendations on the use of brincidofovir to treat in adults. Additionally, the Guidelines for the Prevention and Treatment of Opportunistic Infections in Children with and Exposed to HIV references the (CDC) Clinical Guidance webpage, which includes information on the use of brincidofovir to treat mpox in children and in people with HIV.
The recommended uses may not always be consistent with FDA-approved uses of brincidofovir. See the Adult Guidelines and the CDC’s Clinical Guidance for complete information on recommended uses of brincidofovir in adults and children with HIV. Brincidofovir may have other recommended uses not listed above.
What should I tell my health care provider before taking brincidofovir?
Before taking brincidofovir, tell your health care provider:
- If you are allergic to brincidofovir or any other medicines.
- About any medical conditions you have or have had, including problems or a weakened .
- About anything that could affect your ability to take medicines, such as difficulty swallowing or remembering to take pills.
- If you are pregnant or plan to become pregnant. Brincidofovir should not be used during pregnancy. Talk to your health care provider about the risks of taking brincidofovir during pregnancy.
- If you are breast/chestfeeding or plan to breast/chestfeed. For people with HIV in the United States, the Guideline recommends speaking with your health care provider to discuss options for feeding your baby. People with suppressed have a less than 1% chance of transmitting HIV to their baby via their own milk.
- About other prescription and nonprescription medicines, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Brincidofovir may affect the way other medicines or products work, and other medicines or products may affect how brincidofovir works. Ask your health care provider if there are interactions between brincidofovir and the other medicines you take.
Ask your health care provider about possible side effects from brincidofovir. Your health care provider will tell you what to do if you have side effects.
How should I take brincidofovir?
Take brincidofovir according to your health care provider’s instructions. Your health care provider will tell you how much brincidofovir to take and when to take it. Before you start brincidofovir and each time you get a refill, read any printed information that comes with your medicine.
How should brincidofovir be stored?
- Store brincidofovir tablets and oral suspension at room temperature, 68°F to 77°F (20°C to 25°C). Do not freeze the oral suspension.
- Keep brincidofovir in the container that it came in and keep the container tightly closed.
- Do not use brincidofovir if the original seal over the container opening is broken or missing.
- Throw away brincidofovir that is no longer needed or expired (out of date). Follow FDA guidelines on how to safely dispose of unused medicine.
- Keep brincidofovir and all medicines out of reach of children.
Where can I find more information about brincidofovir?
- Recommendations on the HIV-related uses of brincidofovir, from the Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV.
- CDC webpage Clinical Considerations for Treatment and Prophylaxis of Mpox Infection in People Who are Immunocompromised.
- This Patient Version drug summary is based on the following FDA label(s): Tablet (film coated); Suspension.
- Brincidofovir-related research studies, from ClinicalTrials.gov. (The ClinicalTrials.gov search can be modified so that you can get results that better match your interests.)
Last Reviewed: September 28, 2023